- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 323
MassMutual backs change with $50m Catalyst Fund
The $50m will be split between a fund backing growth-stage companies with black executives and Massachusetts technology developers outside Boston.
Mar 4, 2021Nationwide adds Health Gorilla to portfolio
Nationwide Ventures co-led a $15m series B round for the health data platform developer that included Aflac Corporate Ventures and Epsilon Health Investors.
Mar 3, 2021Maestro conducts $15m series B round
NetEase and Sony Music Entertainment contributed to a round that boosted the livestreaming platform developer's overall funding to $22m.
Mar 3, 2021TeamViewer snags Upskill
Accenture, Boeing, Cisco, Cox, General Electric and Salesforce have exited workplace AR software provider Upskill in a purchase by TeamViewer.
Mar 3, 2021Daily deal net: March 3, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Mar 3, 2021Oscar's initial public offering tops $1.4bn
Ping An and Alphabet-backed health insurer Oscar priced an upsized offering on the New York Stock Exchange above its range to raise $1.44bn.
Mar 3, 2021Instacart gets $265m funding shipment
Fidelity Management and Research co-led a round that more than doubled the Amazon, Comcast and American Express-backed grocery delivery service's valuation to $39bn.
Mar 3, 2021Spire Global spies reverse takeover opportunity
The Qualcomm, Qihoo 360, Mitsui and Itochu-backed space data provider will be valued at $1.6bn and listed on the New York Stock Exchange once the merger closes.
Mar 3, 2021Corporates help eGenesis generate $125m
Xenotransplantation technology developer eGenesis took its total funding to $263m in a series C round backed by Bayer and Fresenius Medical Care.
Mar 3, 2021FogPharma finds $107m in series C
GV returned for a series C round that helped the precision cancer medicine developer increase its overall funding to over $180m.
Mar 3, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


